Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic

Chronic liver disease (CLD) and cirrhosis accounts for approximately 2 million deaths annually worldwide. CLD and cirrhosis-related mortality has increased steadily in the United States.(1,2) With the global pandemic of coronavirus disease 2019 (COVID-19), patients with CLD and cirrhosis represent a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Donghee, Bonham, Clark Andrew, Konyn, Peter, Cholankeril, George, Ahmed, Aijaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the AGA Institute 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271030/
https://www.ncbi.nlm.nih.gov/pubmed/34256143
http://dx.doi.org/10.1016/j.cgh.2021.07.009
Descripción
Sumario:Chronic liver disease (CLD) and cirrhosis accounts for approximately 2 million deaths annually worldwide. CLD and cirrhosis-related mortality has increased steadily in the United States.(1,2) With the global pandemic of coronavirus disease 2019 (COVID-19), patients with CLD and cirrhosis represent a vulnerable population at higher risk for complications and mortality.(3,4) Although high mortality from COVID-19 among patients with CLD and cirrhosis have been reported,(5) national trends in mortality related to CLD and cirrhosis before and during the COVID-19 pandemic have not been assessed. This study estimated the temporal quarterly trends in CLD and cirrhosis-related mortality in the United States from 2017 Q1 to 2020 Q3 using provisional data releases from the National Vital Statistics System.(6,7)

Ejemplares similares